NCT02416869View on ClinicalTrials.gov

Dexamethasone in Lower Third Molar Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Impacted Third Molar Tooth
Interventions
PROCEDURE

Intramuscular application

Patient receive 4mg of Dexamethasone by intramuscular application

PROCEDURE

Submucosal application

Patients receive 4mg of Dexamethasone by submucosal application

DRUG

4mg Dexamethasone submucosal

Patients receive 4mg of submucosal Dexamethasone

DRUG

8mg Dexamethasone submucosal

Patients receive 8mg of submucosal Dexamethasone

PROCEDURE

4mg Dexamethasone preoperative

Patients receive 4mg of Dexamethasone preoperatively

PROCEDURE

4mg Dexamethasone postoperative

Patients receive 4mg of Dexamethasone postoperatively

Trial Locations (1)

11000

School of Dental Medicine, Belgrade

All Listed Sponsors
lead

University of Belgrade

OTHER

NCT02416869 - Dexamethasone in Lower Third Molar Surgery | Biotech Hunter | Biotech Hunter